Novel Approaches for Identification of Broadly Cross-Reactive HIV-1 Neutralizing Human Monoclonal Antibodies and Improvement of Their Potency

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|13|2|203-212

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.2, 2007-01, pp. : 203-212

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potent and broadly neutralizing antibodies targeting HIV envelope protein gp120

By Song Min  

Future Virology, Vol. 7, Iss. 3, 2012-03 ,pp. : 225-227

Future Medicine

Access to resources Recommend Favorite

Immunotherapy of SARS based on combinations of neutralizing human monoclonal antibodies

By Du Lanying   Jiang Shibo  

Future Virology, Vol. 5, Iss. 2, 2010-03 ,pp. : 141-144

Future Medicine

Access to resources Recommend Favorite

Developing Broadly Reactive HIV-1/AIDS Vaccines: A Review of Polyvalent and Centralized HIV-1 Vaccines

By  

Current Pharmaceutical Design, Vol. 13, Iss. 19, 2007-07 ,pp. : 1957-1964

Bentham Science Publishers

Access to resources Recommend Favorite

Structural knowledge of HCV envelope protein region recognized by broadly neutralizing antibodies

By Lavie Muriel   Dubuisson Jean  

Future Virology, Vol. 8, Iss. 10, 2013-10 ,pp. : 949-952

Future Medicine

Access to resources Recommend Favorite

TNF- antagonists: monoclonal antibodies, soluble receptors, thalidomide and other novel approaches

By Marriott J.B.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 8, 1997-08 ,pp. : 1105-1108

Informa Healthcare

Access to resources Recommend Favorite